操纵寨卡病毒RNA的三级结构,用于开发特定组织的减弱疫苗
Xiang Chen1, Meng-Li Cheng2, Xing-Yao Huang1
1State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, 100071, Beijing, China.
EMBO molecular medicine
|September 9, 2025
概括
这项研究表明,改变寨卡病毒RNA结构以阻止宿主蛋白结合,可以产生安全有效的活体减弱疫苗 (LAV). 这种新的疫苗平台提供了对新出现的病毒的保护.
科学领域:
- 病毒学 病毒学
- 疫苗学 疫苗学 疫苗学
- 分子生物学分子生物学
背景情况:
- 活体减弱疫苗 (LAV) 传统上是通过传递或基因工程开发的.
- 病毒RNA结构在宿主蛋白结合中的作用已知,但它们在LAV设计中的使用尚未得到充分探索.
研究的目的:
- 调查针对活体减弱疫苗 (LAV) 开发的病毒RNA结构的潜力.
- 为了设计具有与宿主蛋白质Musashi-1 (MSI1) 结合受损的寨卡病毒 (ZIKV) 突变,以减弱.
主要方法:
- 寨卡病毒 (ZIKV) 是为了破坏特定的病毒RNA元素与Musashi-1 (MSI1) 结合而设计的.
- 在多种动物模型中评估了特定组织的衰减和垂直传播.
- 在小鼠和非人类灵长类动物中评估了对ZIKV挑战的免疫性和保护效果.
主要成果:
- 缺少MSI1结合的ZIKV突变 (MBD) 显示了组织特异性的衰减,在ZIKV易受伤害的组织中受到限制,但不是MSI1缺陷的组织.
- 设计的MBD ZIKV在小鼠中显著减少了垂直传输.
- 用MBD ZIKV进行一次免疫接种引起了强大的免疫反应,并为小鼠和非人类灵长类动物提供了对ZIKV挑战的保护.
结论:
- 针对与宿主蛋白相互作用的病毒RNA结构是开发下一代LAV的可行策略.
- 这种方法为制造针对ZIKV等新兴病毒的减弱疫苗提供了一个强大的平台.
相关概念视频
00:56Viral Structure
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
01:29Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
01:29Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...